Theophylline and Duodenal ulcer aggravated - a phase IV clinical study of FDA data

Summary:

Duodenal ulcer aggravated is reported as a side effect among people who take Theophylline (theophylline), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Atrovent, and have High blood pressure.

The phase IV clinical study analyzes which people have Duodenal ulcer aggravated when taking Theophylline. It is created by eHealthMe based on reports of 18,953 people who have side effects when taking Theophylline from the FDA, and is updated regularly.

What is Theophylline?

Theophylline has active ingredients of theophylline. It is often used in asthma. eHealthMe is studying from 19,150 Theophylline users. Check the latest studies of Theophylline.

What is Duodenal ulcer aggravated?

Duodenal ulcer aggravated is found to be associated with 1,483 drugs and 523 conditions by eHealthMe. Check the latest studies of Duodenal ulcer aggravated.

On Jul, 19, 2026

18,953 people reported to have side effects when taking Theophylline.
Among them, 136 people (0.72%) have Duodenal ulcer aggravated.

Could Theophylline cause Duodenal ulcer aggravated?

Among these 136 people:

How long have people been on Theophylline when they have Duodenal ulcer aggravated? *

Click here to view more results

What is the gender of people who have Duodenal ulcer aggravated when taking Theophylline? *

Click here to view

What is the age of people who have Duodenal ulcer aggravated when taking Theophylline? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Theophylline and have Duodenal ulcer aggravated?

- Check whether Duodenal ulcer aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Theophylline:

Theophylline (19,150 reports)

Duodenal ulcer aggravated treatments and more:

Duodenal ulcer aggravated (25 reports)

How severe was Duodenal ulcer aggravated and when was it recovered:

Duodenal ulcer aggravated in Theophylline

Expand to all the drugs that have ingredients of theophylline:

Duodenal ulcer aggravated and drugs with ingredients of theophylline

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Theophylline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Duodenal ulcer aggravated:

Duodenal ulcer aggravated (1,483 drugs)

Browse all the conditions that are associated with Duodenal ulcer aggravated:

Duodenal ulcer aggravated (523 conditions)

Related publications that referenced our studies

Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on theophylline (the active ingredients of Theophylline) and Theophylline (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.